Fig. 2From: Augmented interpretation of HER2, ER, and PR in breast cancer by artificial intelligence analyzer: enhancing interobserver agreement through a reader study of 201 casesConcordance among pathologists in HER2 (human epidermal growth factor receptor 2) dataset (A), ER (estrogen receptor) dataset (B), and PR (progesterone receptor) dataset (C). Concordance between the consensus of pathologists and the AI (artificial intelligence) analyzer in HER2 dataset (D), ER dataset (E), and PR dataset (F)Back to article page